Dan Lemaitre - 15 May 2023 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
15 May 2023
Net transactions value
-$1,371,194
Form type
4
Filing time
17 May 2023, 16:31:48 UTC
Previous filing
13 Feb 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $34,728 +1,450 +13% $23.95 12,250 15 May 2023 Direct
transaction GMED Class A Common Stock Options Exercise $253,050 +10,500 +86% $24.10 22,750 15 May 2023 Direct
transaction GMED Class A Common Stock Options Exercise $357,280 +14,000 +62% $25.52 36,750 15 May 2023 Direct
transaction GMED Class A Common Stock Options Exercise $459,725 +17,500 +48% $26.27 54,250 15 May 2023 Direct
transaction GMED Class A Common Stock Sale $2,475,977 -43,450 -80% $56.98 10,800 15 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -1,450 -100% $0.000000* 0 15 May 2023 Class A Common Stock 1,450 $23.95 Direct F2
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -10,500 -100% $0.000000* 0 15 May 2023 Class A Common Stock 10,500 $24.10 Direct F3
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -14,000 -100% $0.000000* 0 15 May 2023 Class A Common Stock 14,000 $25.52 Direct F4
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -17,500 -100% $0.000000* 0 15 May 2023 Class A Common Stock 17,500 $26.27 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.77 to $57.215, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 These options were granted on January 23, 2014 and are fully vested.
F3 These options were granted on January 20, 2015 and are fully vested.
F4 These options were granted on January 25, 2016 and are fully vested.
F5 These options were granted on January 30, 2017 and are fully vested.